Published on 12 Aug 2023 on Insider Monkey via Yahoo Finance
Virios Therapeutics, Inc. (NASDAQ:VIRI) Q2 2023 Earnings Call Transcript August 10, 2023
Virios Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.08 EPS, expectations were $-0.07.
Operator: Good day, and welcome to the Virios Therapeutics, Inc. Q2 2023 Earnings Update. At this time, all participants have been placed in a listen-only mode. Please be advised that, today's call being recorded at the company's request. At this time, I would like to turn the call over to Angela Walsh, Senior Vice President, Finance and Treasurer of Virios Therapeutics Inc. Please proceed, Angela.